Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils

American Journal of Respiratory Cell and Molecular Biology

Volumn 34, Issue 6, 2006, Pages 760-765

  Kikuchi, Izumi ^b   Kikuchi, Shinya ^b   Kobayashi, Takehito ^b   Hagiwara, Koichi ^b   Sakamoto, Yoshio ^b   Kanazawa, Minoru ^b   Nagata, Makoto ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Eosinophils; Growth related oncogene ; Interleukin 8; Neutrophils; Trans basement membrane migration

Indexed keywords

APAFANT; BEPAFANT; BIIL 260; DOCEBENONE; GELATINASE B INHIBITOR; GELATINASE INHIBITOR; GM 1489; INTERLEUKIN 8; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BASEMENT MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INCUBATION TIME; INFLAMMATION; NEUTROPHIL; TRANS BASEMENT MEMBRANE MIGRATION;

ADULT; ANTIBODIES, MONOCLONAL; ASTHMA; AZEPINES; BASEMENT MEMBRANE; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; EOSINOPHILS; HUMANS; INTERLEUKIN-8; LAMININ; LEUKOTRIENE B4; MATRIX METALLOPROTEINASE 9; NEUTROPHIL ACTIVATION; NEUTROPHILS; PARACRINE COMMUNICATION; PLATELET ACTIVATING FACTOR; PROTEASE INHIBITORS; PROTEOGLYCANS; PULMONARY EOSINOPHILIA; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744736978     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0303OC     Document Type: Article

References (34)

1. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
2. Flood-Page PT, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barns N, Robinson D, Kay AB. Anti-interleukine-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:1029-1036.
3. Cowbum AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen FK, Holgate ST, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-846.
4. Seymour ML, Rak S, Aberg D, Ruse GC, Penrose JF, Kanaoka Y, Austen FK, Holgate ST, Sampson AP. Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics. Am J Respir Crit Care Med 2001;164:2051-2056.
5. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care Med 1997;156:737-743.
6. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-1336.
7. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008.
8. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353:2213-2214.
9. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multisentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003;22:470-477.
10. Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M. Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. Int Arch Allergy Immunol 2005;137:7-11.
11. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J Immunol 1995;154:4719-4725.
12. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of gluco-corticoids on the rate of apoptosis in neutrophils and eosinophilic granulocytes. J Immunol 1996;156:4422-4428.
13. Teran LM, Carroll MP, Frew AJ, Redington AE, Davies DE, Lindley I, Howarth PH, Church MK, Holgate ST. Leukocyte recruitment after local endobronchial allergen challenge in asthma: relationship to procedure and to airway interleukin-8 release. Am J Respir Crit Care Med 1996;154:469-476.
14. Teran LM, Campos MG, Begishvilli BT, Schroder JM, Djukanovic R, Shute JK, Church MK, Holgate ST, Davies DE. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy 1997;27:396-405.
15. Folkard SG, Westwick J, Millar AB. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J 1997;10:2097-2104.
16. Lampinen M, Rak S, Venge P. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy 1999;29:314-322.
17. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-26.
18. Henson PM, Wenzel SE. Neutrophils and their mediators in asthma. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Boston: Blackwell Scientific; 2000. pp. 503-530.
19. Nagata M, Sedgwick JB, Busse WW. Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation. J mmunol 1995;155:4948-4954.
20. Nagata M, Yamamoto H, Shibasaki M, Sakamoto Y, Matsuo H. Hydrogen peroxide augments eosinophil adhesion via β2 integrin. Immunology 2000;101:412-418.
21. Nagata M, Yamamoto H, Tabe K, Sakamoto Y. Eosinophil transmigration across VCAM-1-expressing endothelial cells is upregulated by antigen-stimulated mononuclear cells. Int Arch Allergy Immunol 2001;125:7-11.
22. Nordström T, Knekt M, Nordström E, Lindqvist C. A microplate-based fluometric assay for monitoring human cancer cell attachment to cortical bone. Anal Biochem 1999;267:37-45.
23. Matsunaga Y, Shono M, Takahashi M, Tsuboi Y, Ogawa K, Yamada T. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction. Br J Pharmacol 2000;130:1539-1546.
24. Schweizer RC, Welmers BA, Raaijmakers JA, Zanen P, Lammres JW, Koenderman L. RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 1994;83:3697-3704.
25. Sedgwick JB, Nagata M. Mechanism of eosinophil activation. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Boston: Blackwell Scientific; 2000. pp. 373-393.
26. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-2681.
27. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519-528.
28. Levin JI, Chen J, Du M, Hogan M, Kincaid S, Nelson FC, Venkatesan AM, Wehr T, Zask A, DiJoseph J, et al. The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups. Bioorg Med Chem Lett 2001;11:2189-2192.
29. Zuurbier AE, Liu L, Mul FP, Verhoeven AJ, Knol EF, Roos D. Neutrophils enhance eosinophil migration across monolayers of lung epithelial cells. Clin Exp Allergy 2001;31:444-452.
30. Ferrante A. Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors. Immunol Ser 1992;57:417-436 .
31. 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989;84:19-26
32. 4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEV1. J Allergy Clin Immunol 1994;94:870-881.
33. Goadby P, Kelly CA, Duddridge M, Ward C, Hendrick DJ, Walters EH. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur Respir J 1990;3:408-413.
34. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmatics. Am J Respir Crit Care Med 1999;159:487-494.